Anebulo Pharmaceuticals Inc (ANEB)
1.59
+0.09
(+6.00%)
USD |
NASDAQ |
Nov 22, 16:00
1.59
0.00 (0.00%)
After-Hours: 16:32
Anebulo Pharmaceuticals Price to Book Value: 21.72 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 20.49 |
| November 20, 2024 | 20.76 |
| November 19, 2024 | 20.76 |
| November 18, 2024 | 20.90 |
| November 15, 2024 | 21.69 |
| November 14, 2024 | 20.76 |
| November 13, 2024 | 21.17 |
| November 12, 2024 | 22.54 |
| November 11, 2024 | 23.08 |
| November 08, 2024 | 22.26 |
| November 07, 2024 | 20.08 |
| November 06, 2024 | 25.54 |
| November 05, 2024 | 25.13 |
| November 04, 2024 | 25.81 |
| November 01, 2024 | 25.13 |
| October 31, 2024 | 25.68 |
| October 30, 2024 | 25.27 |
| October 29, 2024 | 25.88 |
| October 28, 2024 | 24.99 |
| October 25, 2024 | 24.99 |
| October 24, 2024 | 25.95 |
| October 23, 2024 | 25.81 |
| October 22, 2024 | 25.14 |
| October 21, 2024 | 25.40 |
| October 18, 2024 | 26.79 |
| Date | Value |
|---|---|
| October 17, 2024 | 24.99 |
| October 16, 2024 | 25.81 |
| October 15, 2024 | 25.95 |
| October 14, 2024 | 24.99 |
| October 11, 2024 | 25.68 |
| October 10, 2024 | 25.54 |
| October 09, 2024 | 26.63 |
| October 08, 2024 | 25.81 |
| October 07, 2024 | 26.16 |
| October 04, 2024 | 26.63 |
| October 03, 2024 | 26.09 |
| October 02, 2024 | 27.04 |
| October 01, 2024 | 27.11 |
| September 30, 2024 | 26.36 |
| September 27, 2024 | 13.94 |
| September 26, 2024 | 13.33 |
| September 25, 2024 | 12.58 |
| September 24, 2024 | 14.22 |
| September 23, 2024 | 15.10 |
| September 20, 2024 | 20.95 |
| September 19, 2024 | 14.15 |
| September 18, 2024 | 13.60 |
| September 17, 2024 | 15.44 |
| September 16, 2024 | 14.22 |
| September 13, 2024 | 14.15 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.400
Minimum
Oct 21 2022
27.11
Maximum
Oct 01 2024
8.488
Average
7.487
Median
Nov 11 2021
Price to Book Value Benchmarks
| Revance Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 3.142 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.361 |
| Theriva Biologics Inc | 0.1457 |
Price to Book Value Related Metrics
| Price | 1.59 |
| Earnings Yield | -18.87% |
| Market Cap | 41.23M |